rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Carlos Paya V

Director

Company insider

Files Form 4 as: Director, Vaxcyte; Director, Collegium Pharmaceutical; Director, Standard BioTools; Director, Mallinckrodt; President and CEO, Immune Design.

Every Form 4 they filed

In numbers

Trades disclosed
105
Buys
0
Sells
4
Bought
$0
Sold
$82K
Companies
5
Companies where not an officer
4
First trade
7 Jan 2015
Last trade
15 Jun 2026
Last filed
16 Jun 2026

Companies traded

Where they are an officer
Immune DesignDirector, Officer · last 2 Apr 20190 buys · 3 sells
Everywhere else they filed: board seats, 10% stakes, other companies
PCVX VaxcyteDirector · Biotechnology · last 15 Jun 20260 buys · 0 sells
COLL Collegium PharmaceuticalDirector · Pharmaceuticals · last 14 May 20260 buys · 0 sells
LAB Standard BioToolsDirector · Life-science tools · last 14 Jun 20230 buys · 0 sells
MallinckrodtDirector · last 12 Mar 20210 buys · 1 sell

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
15 Jun 2026filed 16 Jun 2026PCVX VaxcyteBiotechnologySEC FORM 4 Code A—2,265 at $0.00filing
15 Jun 2026filed 16 Jun 2026PCVX Vaxcyteoption or derivative · BiotechnologySEC FORM 4 Code A—11,389 at $0.00filing
15 Jun 2026filed 16 Jun 2026PCVX Vaxcyteoption or derivative · BiotechnologySEC FORM 4 Code A—11,389 at $0.00filing
15 Jun 2026filed 16 Jun 2026PCVX VaxcyteBiotechnologySEC FORM 4 Code A—2,265 at $0.00filing
14 May 2026filed 18 May 2026COLL Collegium PharmaceuticalPharmaceuticalsSEC FORM 4 Code A—8,741 at $0.00filing
14 May 2026filed 18 May 2026COLL Collegium PharmaceuticalPharmaceuticalsSEC FORM 4 Code A—8,741 at $0.00filing
12 Jun 2025filed 16 Jun 2025PCVX Vaxcyteoption or derivative · BiotechnologySEC FORM 4 Code A—15,372 at $0.00filing
12 Jun 2025filed 16 Jun 2025PCVX VaxcyteBiotechnologySEC FORM 4 Code A—3,041 at $0.00filing
15 May 2025filed 19 May 2025COLL Collegium PharmaceuticalPharmaceuticalsSEC FORM 4 Code A—19,582 at $0.00filing
9 Dec 2024filed 10 Dec 2024PCVX Vaxcyteoption or derivative · BiotechnologySEC FORM 4 Code G—7,250 at $0.00filing
9 Dec 2024filed 10 Dec 2024PCVX Vaxcyteoption or derivative · BiotechnologySEC FORM 4 Code A—7,250 at $0.00filing
6 Dec 2024filed 10 Dec 2024PCVX VaxcyteBiotechnologySEC FORM 4 Code G—2,500 at $0.00filing
6 Dec 2024filed 10 Dec 2024PCVX VaxcyteBiotechnologySEC FORM 4 Code A—2,500 at $0.00filing
6 Jun 2024filed 10 Jun 2024PCVX Vaxcyteoption or derivative · BiotechnologySEC FORM 4 Code A—7,250 at $0.00filing
6 Jun 2024filed 10 Jun 2024PCVX VaxcyteBiotechnologySEC FORM 4 Code A—1,550 at $0.00filing
9 Nov 2023filed 9 Nov 2023PCVX Vaxcyteoption or derivative · BiotechnologySEC FORM 4 Code G—30,000 at $0.00filing
9 Nov 2023filed 9 Nov 2023PCVX Vaxcyteoption or derivative · BiotechnologySEC FORM 4 Code G—30,000 at $0.00filing
9 Nov 2023filed 9 Nov 2023PCVX Vaxcyteoption or derivative · BiotechnologySEC FORM 4 Code G—18,750 at $0.00filing
9 Nov 2023filed 9 Nov 2023PCVX Vaxcyteoption or derivative · BiotechnologySEC FORM 4 Code G—18,750 at $0.00filing
9 Nov 2023filed 9 Nov 2023PCVX Vaxcyteoption or derivative · BiotechnologySEC FORM 4 Code G—15,000 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Not placed4

Buys in green, sells in red, by the company’s sector.

Related people

Nobody else traded the same names lately.